Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem Cell Educator Therapy in Type 1 Diabetes
NCT02624804Phase 1Completed
- Sponsor
- Hackensack Meridian Health
- Start
- Jun 2017
- Primary completion
- Nov 2022
- Modality
- Stem Cell Therapies, Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Stem Cell Educator Therapy in type 1 diabetes mellitus (T1D), sponsored by Hackensack Meridian Health. Primary endpoint: Number of Participants With Treatment Related Adverse Events at 12 months. Started Jun 2017; status: completed.
02
Drugs
Stem Cell Educator Therapy
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02624804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02624804.